BIO-RAD LABORATORIES, INC.
BIOdata completeness 100%18 fiscal years on filei. The business — what you’d actually own
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $2.92B1 | $2.8B2 | $2.67B3 | $2.57B3 | $2.58B3 |
| Net income | $4.25B4 | −$3.63B5 | −$637.3M6 | −$1.84B6 | $759.9M6 |
| Operating cash flow | $669.5M7 | $194.4M8 | $374.9M9 | $455.2M9 | $532.2M9 |
| Capital expenditure | $133.7M10 | $112.8M11 | $156.7M12 | $165.6M12 | $157.6M12 |
| Free cash flow (derived) | $535.7M7 | $81.6M8 | $218.2M9 | $289.6M9 | $374.6M9 |
| Total debt | — | $1.2B13 | $2.41B14 | $2.4B15 | $2.4B15 |
| Cash & equivalents | $470.8M16 | $434.2M17 | $403.8M18 | $488.1M18 | $529.8M18 |
| Diluted shares | 30.2M | 29.8M | 29.2M | 28.2M | 27.3M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
ii. Your slice — ownership made literal
If you owned
shares
You’d own
0.000037%
of the whole company
Your share of last year’s profit
$278.55
Your share of its debt
$881.46
Your share of free cash flow
$137.31
iii. What it’s worth — engine v0.1.0
DCF · Growth Exit 10Y
$74.83
assumptions (10)
- riskFreeRate4.5%
- equityRiskPremium5.0%
- beta100.0%
- equityWeight85.0%
- costOfDebtSpread1.5%
- taxRate21.0%
- terminalGrowth2.5%
- projectionYears10
- fcfGrowth0.0%
- fcfBase$289.6M
DCF · Growth Exit 5Y
$86.64
assumptions (10)
- riskFreeRate4.5%
- equityRiskPremium5.0%
- beta100.0%
- equityWeight85.0%
- costOfDebtSpread1.5%
- taxRate21.0%
- terminalGrowth2.5%
- projectionYears5
- fcfGrowth0.0%
- fcfBase$289.6M
Earnings Power Value
not applicable
normalized (5y-median) earnings non-positive — EPV undefined
Graham Number
$413.77
assumptions (1)
- grahamMultiplier2250.0%
Different models answer different questions — which to trust when →
iv. The price question — last, on purpose
What does today’s price assume?
Type a price. The ledger answers.
Or set your own belief
FCF growth, next 5 years0.0%
Discount rate (WACC)8.78%
Terminal growth2.5%
At your growth, a share is worth $86.64
Default growth 0.0%= this company’s own filed history (median-to-median FCF CAGR, clamped 0–20%). Your adjustments are recorded anonymously. They become the “what do owners actually believe” dataset.
Sources — the receipts
- 10-K · period ending 2021-12-31 · accession 0000012208-24-000013 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2022-12-31 · accession 0000012208-25-000007 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2023-12-31 · accession 0000012208-26-000010 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2021-12-31 · accession 0000012208-24-000013 (NetIncomeLoss)
- 10-K · period ending 2022-12-31 · accession 0000012208-25-000007 (NetIncomeLoss)
- 10-K · period ending 2023-12-31 · accession 0000012208-26-000010 (NetIncomeLoss)
- 10-K · period ending 2021-12-31 · accession 0000012208-24-000013 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0000012208-25-000007 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-31 · accession 0000012208-26-000010 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2021-12-31 · accession 0000012208-24-000013 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-12-31 · accession 0000012208-25-000007 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-12-31 · accession 0000012208-26-000010 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-12-31 · accession 0000012208-24-000013 (LongTermDebtNoncurrent)
- 10-K · period ending 2023-12-31 · accession 0000012208-25-000007 (LongTermDebtNoncurrent)
- 10-K · period ending 2024-12-31 · accession 0000012208-26-000010 (LongTermDebtNoncurrent)
- 10-K · period ending 2021-12-31 · accession 0000012208-24-000013 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-12-31 · accession 0000012208-25-000007 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-12-31 · accession 0000012208-26-000010 (CashAndCashEquivalentsAtCarryingValue)